Do demographic and clinical features and comorbidities affect the risk of spread to an additional body site in functional motor disorders?

Functional motor disorders Functional neurological disorders Outcome Phenotypic change Spread

Journal

Journal of neural transmission (Vienna, Austria : 1996)
ISSN: 1435-1463
Titre abrégé: J Neural Transm (Vienna)
Pays: Austria
ID NLM: 9702341

Informations de publication

Date de publication:
10 2022
Historique:
received: 09 06 2022
accepted: 06 08 2022
pubmed: 17 8 2022
medline: 15 9 2022
entrez: 16 8 2022
Statut: ppublish

Résumé

The aim of this study is to assess changes in the body distribution and the semeiology of functional motor disorder (FMD) in patients who reported only one or more than one body site affected at FMD onset. Data were obtained from the Italian Registry of Functional Motor Disorders, which included patients with a diagnosis of clinically definite FMDs. The relationship between FMD features and spread to other body sites was estimated by multivariate Cox regression analysis. We identified 201 (49%) patients who reported only one body site affected at FMD onset and 209 (51%) who reported multiple body sites affected at onset. FMD spread from the initial site to another site in 43/201 (21.4%) patients over 5.7 ± 7.1 years in those with only one site affected at FMD onset; FMD spread to an another body site in 29/209 (13.8%) over 5.5 ± 6.5 years. The spread of FMD was associated with non-motor functional symptoms and psychiatric comorbidities only in the patients with one body site affected at FMD onset. Our findings provide novel insight into the natural history of FMD. The number of body sites affected at onset does not seem to have a consistent influence on the risk of spread. Furthermore, our findings suggest that psychiatric comorbidities and non-motor functional symptoms may predict the spread of FMD symptoms, at least in patients with one body site affected at onset.

Identifiants

pubmed: 35972697
doi: 10.1007/s00702-022-02537-x
pii: 10.1007/s00702-022-02537-x
pmc: PMC9468120
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1271-1276

Informations de copyright

© 2022. The Author(s).

Références

Neurol Sci. 2021 Oct;42(10):3989-3990
pubmed: 34324120
Mov Disord. 2020 Nov;35(11):2038-2045
pubmed: 32662572
J Neurol. 2021 Dec;268(12):4737-4743
pubmed: 33961091
J Neuropsychiatry Clin Neurosci. 2020 Winter;32(1):33-42
pubmed: 31865871
J Neurol Neurosurg Psychiatry. 2014 Feb;85(2):220-6
pubmed: 24029543
BMJ. 2020 Oct 21;371:m3745
pubmed: 33087335
Curr Opin Neurol. 2009 Aug;22(4):430-6
pubmed: 19542886
Parkinsonism Relat Disord. 2020 Feb;71:40-43
pubmed: 32007783
J Neurol Neurosurg Psychiatry. 2022 Jun;93(6):609-616
pubmed: 35217516
Eur J Neurol. 2021 May;28(5):1752-1758
pubmed: 33300269
J Neural Transm (Vienna). 2020 Oct;127(10):1435-1439
pubmed: 32851476
Lancet Neurol. 2022 Jun;21(6):537-550
pubmed: 35430029
Front Neurol. 2020 Nov 05;11:582215
pubmed: 33250849
Mov Disord Clin Pract. 2020 Sep 22;7(8):920-929
pubmed: 33163563
J Neurol Neurosurg Psychiatry. 2012 Aug;83(8):842-50
pubmed: 22661497
JAMA Neurol. 2018 Sep 1;75(9):1132-1141
pubmed: 29868890

Auteurs

Tommaso Ercoli (T)

Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Michele Tinazzi (M)

Neurology Unit, Movement Disorders Division, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, P.le Scuro 10, 37134, Verona, Italy. michele.tinazzi@univr.it.

Christian Geroin (C)

Neurology Unit, Movement Disorders Division, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, P.le Scuro 10, 37134, Verona, Italy. christian.geroin@univr.it.

Enrico Marcuzzo (E)

Neurology Unit, Movement Disorders Division, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, P.le Scuro 10, 37134, Verona, Italy.

Roberto Erro (R)

Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, Baronissi, SA, Italy.

Sofia Cuoco (S)

Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, Baronissi, SA, Italy.

Roberto Ceravolo (R)

Center for NeuroDegenerative Diseases Parkinson and Movement Disorders, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Sonia Mazzucchi (S)

Center for NeuroDegenerative Diseases Parkinson and Movement Disorders, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Andrea Pilotto (A)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
FERB Onlus, Ospedale S. Isidoro, Trescore Balneario, Bergamo, Italy.

Alessandro Padovani (A)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Luigi Michele Romito (LM)

Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Roberto Eleopra (R)

Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Mario Zappia (M)

Department G.F. Ingrassia, Section of Neurosciences, University of Catania, Catania, Italy.

Alessandra Nicoletti (A)

Department G.F. Ingrassia, Section of Neurosciences, University of Catania, Catania, Italy.

Carlo Dallocchio (C)

Department of Medical Area, Neurology Unit, ASST Pavia, Pavia, Italy.

Carla Arbasino (C)

Department of Medical Area, Neurology Unit, ASST Pavia, Pavia, Italy.

Francesco Bono (F)

Botulinum Toxin Center, Neurology Unit A.O.U. Mater Domini, Catanzaro, Italy.

Giorgio Spano (G)

Botulinum Toxin Center, Neurology Unit A.O.U. Mater Domini, Catanzaro, Italy.

Benedetta Demartini (B)

Aldo Ravelli Research Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, University of Milan, Milan, Italy.

Orsola Gambini (O)

Aldo Ravelli Research Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, University of Milan, Milan, Italy.

Nicola Modugno (N)

IRCCS Neuromed, Pozzilli, Italy.

Enrica Olivola (E)

IRCCS Neuromed, Pozzilli, Italy.

Laura Bonanni (L)

Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio, Chieti-Pescara, Italy.

Alberto Albanese (A)

Department of Neurology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.

Gina Ferrazzano (G)

Department of Human Neurosciences, Sapienza, University of Rome, Rome, Italy.

Alessandro Tessitore (A)

Department of Advanced Medical and Surgery Sciences, University of Campania-Luigi Vanvitelli, Naples, Italy.

Leonardo Lopiano (L)

Department of Neuroscience-Rita Levi Montalcini, University of Turin, Turin, Italy.

Giovanna Calandra-Buonaura (G)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

Martina Petracca (M)

Movement Disorder Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Francesca Morgante (F)

Neurosciences Research Centre, Molecular and Clinical Sciences Neurosciences Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK.
Department of Experimental and Clinical Medicine, University of Messina, Messina, Italy.

Marcello Esposito (M)

Clinical Neurophysiology Unit, Cardarelli Hospital, Naples, Italy.

Antonio Pisani (A)

IRCCS Mondino Foundation, Pavia, Italy.
Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.

Paolo Manganotti (P)

Clinical Neurology Unit, Department of Medical, Surgical and Health Services, University of Trieste, Trieste, Italy.

Lucia Tesolin (L)

Functional Movement Disorders Outpatient Clinic, Clinical Neurology and Stroke Unit, Central Country Hospital, Bolzano, Italy.

Francesco Teatini (F)

Functional Movement Disorders Outpatient Clinic, Clinical Neurology and Stroke Unit, Central Country Hospital, Bolzano, Italy.

Fabrizio Stocchi (F)

University and Institute of Research and Medical Care San Raffaele Roma, Rome, Italy.

Giovanni Defazio (G)

Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH